Baxter Healthcare Corporation recalls Clindamycin Injection USP in 5% Dextrose
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations
- Products
-
- Clindamycin Injection USP in 5% Dextrose
- Where it was sold
-
US Nationwide; Puerto Rico; and Chile.
Nationwide
- Units affected
- N/A
- About this recall
- Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.